초록 열기/닫기 버튼

본 연구에서는 간경병증 환자의 원인질병인 만성 B형간염, 만성 C형간염, 알코올성 간질환이 재원일수에 미치는 영향을 분석하였다. 건강보험심사평가원의 2013, 2014년 입원환자데이터를 이용하여 간경병증 환자를 K740∼K746(만성 B형간염(B180, B181)), 만성 C형간염(B182), 알코올성 간질환(K70, K701, K7010, K7011))으로 정의하였다. 총 147명을 대상으로 간경병증 환자의 특성에 따른 원인상병의 차이와 간경병증 환자의 원인상병이 재원일수에 미치는 영향을 분석하였다. 독립변수는 성별, 연령, 의료보장 유형, 진료결과(퇴원, 사망)를 사용하였으며, 종속변수는 재원일수로 하여 포아송 회귀분석을 실시하였다. 본 연구결과, 간경병증 환자는 만성 B형간염, 만성 C형간염, 알코올성 간질환의 원인질환 상병을 동반하며 원인질환에 따라 재원일수에 차이가 있었고, 특히 만성 C형간염을 동반한 간경병증 환자는 만성 B형간염 환자에 비해 재원일수가 1.2배(20%) 증가된 것을 확인하였다. 만성 C형간염의 예방 및 바이러스보유자에 대한 선별검사를 통해 특별한 증상이 없는 초기 단계에 이들을 찾아내고, 이를 적절한 관리체계에 포함하는 임상적 관리방안을 모색할 필요가 있겠다.


The purpose of this study was to investigate the effects of chronic hepatitis B, chronic hepatitis C, and alcoholic liver disease, which are the cause of diseases in patients with liver cirrhosis, on length of stays. Patients with cirrhosis of the liver were defined as K740 to K746 using Health Insurance Review and Assessment Service National Inpatient Sample in 2013 and 2014 (Chronic hepatitis B (B180, B181), chronic hepatitis C (B182), alcoholic liver disease (K70, K701, K7010, K7011)). In a total of 147 patients, the difference in cause of diseases according to the characteristics of cirrhosis patients and the effect of cause of diseases in patients with liver cirrhosis on length of stay were analyzed. In the Poisson regression analysis, sex, age, type of medical coverage, treatment outcome (discharge, death) were used as independent variables, and length of stays were used as dependent variables. As a result of this study, patients with cirrhosis were accompanied by the cause of diseases of chronic hepatitis B, chronic hepatitis C, and alcoholic liver disease. In particular, it was confirmed that patients with cirrhosis with chronic hepatitis C had a 1.2-fold (20%) increase in length of stays compared to patients with chronic hepatitis B. Through the prevention of chronic hepatitis C infection and screening tests for virus carriers, it is necessary to find them in the early stages without any special symptoms, and seek clinical management plans to include them in an appropriate management system.